Suppr超能文献

Leucas aspera 对 D-半乳糖胺诱导的大鼠肝损伤的保肝和抗氧化作用。

Hepatoprotective and antioxidant activity of Leucas aspera against D-galactosamine induced liver damage in rats.

机构信息

Department of Pharmacology, PSG College of Pharmacy, Coimbatore, Tamil Nadu, India.

出版信息

Pharm Biol. 2012 Dec;50(12):1592-5. doi: 10.3109/13880209.2012.685130. Epub 2012 Sep 20.

Abstract

CONTEXT

Whole plant of Leucas aspera (LA) Willd. (Labiatae) is traditionally used in Siddha medicine for hepatic ailments.

OBJECTIVE

LA was investigated for its hepatoprotective, antioxidant, and protective effect on microsomal drug metabolizing enzymes (MDMEs).

MATERIALS AND METHODS

LA aqueous extract (200 and 400 mg/kg, p.o.) was evaluated for its hepatoprotective and antioxidant activity in d-galactosamine (D-GalN)-induced hepatotoxicity in rats. Biochemical and histopathological studies were performed to assess hepatoprotective activity. Hexobarbitone-induced sleeping time model was used to study the protective effect of LA on MDMEs.

RESULTS

D-GalN administration induced hepatotoxicity in rats which was manifested by increased levels of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, total cholesterol, triglycerides, total bilirubin and oxidative stress. Pretreatment with LA extract significantly protected the liver in D-GalN administered rats. LA extract significantly elevated antioxidant enzymes like superoxide dismutase, catalase, glutathione peroxidase and decreased lipid peroxidation levels in liver. The total phenolic and flavonoid content in LA aqueous extract was found to be 28.33 ± 0.19 gallic acid equivalents mg/g of extract and 3.96 ± 0.57 rutin equivalent mg/g of extract, respectively. LA extract (200 and 400 mg/Kg) treatment with CCl₄ decreased the hexobarbitone-induced sleeping time in mice by 56.67 and 71.30%, respectively, which indicated the protective effect of LA on hepatic MDMEs. Histological studies showed that LA at 400 mg/kg attenuated the hepatocellular necrosis in D-GalN intoxicated rats.

CONCLUSION

Our results contribute towards validation of the traditional use of LA in hepatic disorders.

摘要

背景

印度筋骨草(LA)全草被传统上用于治疗肝脏疾病的顺势疗法。

目的

研究 LA 对肝保护、抗氧化和对微粒体药物代谢酶(MDME)的保护作用。

材料和方法

以 200 和 400mg/kg 灌胃给药的方式,评价 LA 在半乳糖胺(D-GalN)诱导的大鼠肝毒性中的肝保护和抗氧化活性。进行生物化学和组织病理学研究以评估肝保护活性。使用戊巴比妥钠诱导的睡眠时间模型来研究 LA 对 MDMEs 的保护作用。

结果

D-GalN 给药导致大鼠肝毒性,表现为丙氨酸氨基转移酶、天冬氨酸氨基转移酶、碱性磷酸酶、总胆固醇、甘油三酯、总胆红素和氧化应激水平升高。LA 提取物预处理显著保护了 D-GalN 给药大鼠的肝脏。LA 提取物显著提高了超氧化物歧化酶、过氧化氢酶、谷胱甘肽过氧化物酶等抗氧化酶的水平,并降低了肝脂质过氧化水平。LA 水提物中的总酚和类黄酮含量分别为 28.33±0.19 没食子酸当量 mg/g 提取物和 3.96±0.57 芦丁当量 mg/g 提取物。LA 提取物(200 和 400mg/Kg)与 CCl₄ 一起处理可使小鼠戊巴比妥钠诱导的睡眠时间分别减少 56.67%和 71.30%,这表明 LA 对肝 MDMEs 的保护作用。组织学研究表明,LA 在 400mg/kg 时可减轻 D-GalN 中毒大鼠的肝细胞坏死。

结论

我们的结果为 LA 在肝脏疾病中的传统应用提供了验证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验